NCT00002100View on ClinicalTrials.gov

Phase I/II Study of Curdlan Sulfate

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Curdlan sulfate

Trial Locations (1)

94109

ViRx Inc, San Francisco

Sponsors

Lead Sponsor

AJI Pharma USA
All Listed Sponsors
lead

AJI Pharma USA

INDUSTRY

NCT00002100 - Phase I/II Study of Curdlan Sulfate | Biotech Hunter | Biotech Hunter